Trial Information
A Randomized Controlled Trial of Endobronchial or Endoscopic Ultrasound as a First Test in the Diagnosis and Staging of Lung Cancer
Inclusion Criteria:
- Consecutive patients suspected of lung cancer on CT scan
- Written informed consent
- Able to tolerate bronchoscopy and thoracic surgery
Exclusion Criteria:
- Evidence of severe or uncontrolled systemic disease that makes it undesirable for the
patient to participate in the trial
- Any disorder making reliable informed consent impossible
- Patients with extra-thoracic disease, supraclavicular lymphadenopathy or pleural
effusion
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Time from first outpatient appointment to decision to treat
Outcome Time Frame:
1 - 3 months
Safety Issue:
No
Principal Investigator
Stephen Spiro, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Univeristy College London NHS Trust
Authority:
United Kingdom: Research Ethics Committee
Study ID:
07/0156
NCT ID:
NCT00652769
Start Date:
March 2008
Completion Date:
July 2012
Related Keywords:
- Bronchogenic Carcinoma
- Lung
- Cancer
- Staging
- Endobronchial
- Ultrasound
- Endoscopic
- Carcinoma
- Carcinoma, Bronchogenic
- Lung Neoplasms